Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 17.8814.4415.5819.616.20

What is the latest Price to Cash Earnings (PCE) ratio of AARTI DRUGS ?

The latest Price to Cash Earnings (PCE) ratio of AARTI DRUGS is 17.88 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202417.88
Mar202314.44
Mar202215.58
Mar202119.61
Mar20206.20

How is Price to Cash Earnings (PCE) of AARTI DRUGS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 17.88
23.82
Mar2023 14.44
-7.32
Mar2022 15.58
-20.55
Mar2021 19.61
216.29
Mar2020 6.2 -

Other Financial Ratios of AARTI DRUGS


Compare Price to Cash Earnings (PCE) ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,594.9 Cr -5.6% -6.3% -24.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -3.1% -3.9% 12.9% Stock Analytics
DIVIS LABORATORIES ₹157,931.0 Cr -2.9% -0.8% 62.5% Stock Analytics
CIPLA ₹117,322.0 Cr 1.1% 0.3% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,116.0 Cr -1.3% -9.4% -0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹94,752.0 Cr -3.7% -5.9% 19.7% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-5.6%

-6.3%

-24.1%

SENSEX

-2.9%

-0.1%

6.8%


You may also like the below Video Courses